摘要
Key points:With aging,there is increased nucleotide-binding oligomerization domain-(NOD-)like receptor(NLR) protein-3(NLRP3) activation in neural and ocular tissues.Activation of the NLRP3 inflammasome appears to be a common denominator in the pathogenesis of age-related diseases of the eye and brain.Pharmacological inhibition of the NLRP3 inflammasome may be a potent therapy for preventing the development and progression of age-related eye and brain diseases.
基金
supported by a Neurological Foundation First Postdoctoral Research Fellowship(2001 FFE)
an Auckland Medical Research Foundation Grant (1121013)(to OOM)。
